Doximity, Inc. (NASDAQ:DOCS) Receives $69.37 Average PT from Analysts

Shares of Doximity, Inc. (NASDAQ:DOCS) have been given an average recommendation of “Moderate Buy” by the twenty-two research firms that are presently covering the firm, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a sell rating, eight have issued a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the company. The average 12-month target price among brokers that have issued a report on the stock in the last year is $70.4211.

Several brokerages have weighed in on DOCS. Bank of America raised Doximity from a “neutral” rating to a “buy” rating and boosted their price objective for the stock from $75.00 to $82.00 in a report on Monday. Zacks Research cut Doximity from a “strong-buy” rating to a “hold” rating in a report on Wednesday, August 20th. Evercore ISI boosted their price objective on Doximity from $75.00 to $81.00 and gave the stock an “outperform” rating in a report on Wednesday, October 8th. Canaccord Genuity Group boosted their price objective on Doximity from $59.00 to $67.00 and gave the stock a “hold” rating in a report on Thursday, September 18th. Finally, Needham & Company LLC boosted their price objective on Doximity from $67.00 to $75.00 and gave the stock a “buy” rating in a report on Friday, August 8th.

Insiders Place Their Bets

In other news, Director Regina M. Benjamin sold 5,000 shares of the business’s stock in a transaction dated Friday, October 10th. The stock was sold at an average price of $70.84, for a total transaction of $354,200.00. Following the completion of the transaction, the director directly owned 19,839 shares in the company, valued at approximately $1,405,394.76. The trade was a 20.13% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Timothy S. Cabral sold 20,000 shares of the business’s stock in a transaction dated Wednesday, September 24th. The stock was sold at an average price of $75.00, for a total value of $1,500,000.00. Following the transaction, the director owned 3,221 shares of the company’s stock, valued at $241,575. The trade was a 86.13% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 37,000 shares of company stock valued at $2,635,880. 31.30% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Doximity

Several institutional investors have recently modified their holdings of the stock. Vanguard Group Inc. grew its position in shares of Doximity by 8.8% during the 1st quarter. Vanguard Group Inc. now owns 12,194,492 shares of the company’s stock worth $707,646,000 after buying an additional 990,923 shares during the period. William Blair Investment Management LLC grew its position in shares of Doximity by 13.8% during the 2nd quarter. William Blair Investment Management LLC now owns 5,219,394 shares of the company’s stock worth $320,158,000 after buying an additional 634,927 shares during the period. Geode Capital Management LLC grew its position in shares of Doximity by 7.7% during the 2nd quarter. Geode Capital Management LLC now owns 3,639,898 shares of the company’s stock worth $223,829,000 after buying an additional 261,319 shares during the period. Franklin Resources Inc. grew its position in shares of Doximity by 53.9% during the 2nd quarter. Franklin Resources Inc. now owns 3,162,593 shares of the company’s stock worth $193,993,000 after buying an additional 1,108,162 shares during the period. Finally, Invesco Ltd. grew its position in shares of Doximity by 54.8% during the 1st quarter. Invesco Ltd. now owns 1,969,326 shares of the company’s stock worth $114,280,000 after buying an additional 696,923 shares during the period. 87.19% of the stock is currently owned by institutional investors and hedge funds.

Doximity Stock Up 2.4%

Doximity stock opened at $68.47 on Thursday. The stock has a 50-day simple moving average of $69.65 and a 200 day simple moving average of $61.94. Doximity has a 12-month low of $41.03 and a 12-month high of $85.21. The stock has a market capitalization of $12.82 billion, a price-to-earnings ratio of 68.47, a P/E/G ratio of 4.10 and a beta of 1.38.

Doximity (NASDAQ:DOCS) last released its quarterly earnings results on Thursday, August 7th. The company reported $0.36 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.31 by $0.05. Doximity had a return on equity of 21.75% and a net margin of 36.60%.Doximity’s revenue for the quarter was up 15.2% on a year-over-year basis. During the same period in the previous year, the business earned $0.28 earnings per share. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. As a group, sell-side analysts anticipate that Doximity will post 0.99 EPS for the current year.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.